BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 27832939)

  • 61. The structural basis for tight control of PP2A methylation and function by LCMT-1.
    Stanevich V; Jiang L; Satyshur KA; Li Y; Jeffrey PD; Li Z; Menden P; Semmelhack MF; Xing Y
    Mol Cell; 2011 Feb; 41(3):331-42. PubMed ID: 21292165
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mouse model for probing tumor suppressor activity of protein phosphatase 2A in diverse signaling pathways.
    Walter G; Ruediger R
    Cell Cycle; 2012 Feb; 11(3):451-9. PubMed ID: 22262169
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Regulation of the phosphoprotein phosphatase 2A system and its modulation during oxidative stress: A potential therapeutic target?
    Elgenaidi IS; Spiers JP
    Pharmacol Ther; 2019 Jun; 198():68-89. PubMed ID: 30797822
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Targeting PP2A in cancer: Combination therapies.
    Mazhar S; Taylor SE; Sangodkar J; Narla G
    Biochim Biophys Acta Mol Cell Res; 2019 Jan; 1866(1):51-63. PubMed ID: 30401535
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The interaction of SET and protein phosphatase 2A as target for cancer therapy.
    Dacol EC; Wang S; Chen Y; Lepique AP
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188578. PubMed ID: 34116173
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Targeting protein phosphatase PP2A for cancer therapy: development of allosteric pharmaceutical agents.
    Brautigan DL; Farrington C; Narla G
    Clin Sci (Lond); 2021 Jul; 135(13):1545-1556. PubMed ID: 34192314
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The 48-kDa alternative translation isoform of PP2A:B56epsilon is required for Wnt signaling during midbrain-hindbrain boundary formation.
    Jin Z; Shi J; Saraf A; Mei W; Zhu GZ; Strack S; Yang J
    J Biol Chem; 2009 Mar; 284(11):7190-200. PubMed ID: 19129191
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Overexpression of the catalytic subunit of protein phosphatase 2A impairs cardiac function.
    Gergs U; Boknik P; Buchwalow I; Fabritz L; Matus M; Justus I; Hanske G; Schmitz W; Neumann J
    J Biol Chem; 2004 Sep; 279(39):40827-34. PubMed ID: 15247211
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Identification and functional analysis of variant haplotypes in the 5'-flanking region of protein phosphatase 2A-Bδ gene.
    Chen HF; Lin LN; Chen YX; Wan JX; Luo J; Zhang CZ; Li XJ; Hu YM; Mai JR; Chen W; Lin ZN; Lin YC
    PLoS One; 2012; 7(4):e35524. PubMed ID: 22539979
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cardiac myosin binding protein-C phosphorylation as a function of multiple protein kinase and phosphatase activities.
    Kampourakis T; Ponnam S; Campbell KS; Wellette-Hunsucker A; Koch D
    Nat Commun; 2024 Jun; 15(1):5111. PubMed ID: 38877002
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Roles of phosphotase 2A in nociceptive signal processing.
    Wang Y; Lei Y; Fang L; Mu Y; Wu J; Zhang X
    Mol Pain; 2013 Sep; 9():46. PubMed ID: 24010880
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A tumor suppressor role for PP2A-B56alpha through negative regulation of c-Myc and other key oncoproteins.
    Arnold HK; Sears RC
    Cancer Metastasis Rev; 2008 Jun; 27(2):147-58. PubMed ID: 18246411
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Interaction mechanism of endogenous PP2A inhibitor protein ENSA with PP2A.
    Thapa C; Roivas P; Haataja T; Permi P; Pentikäinen U
    FEBS J; 2022 Jan; 289(2):519-534. PubMed ID: 34346186
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The structure of human leucine carboxyl methyltransferase 1 that regulates protein phosphatase PP2A.
    Tsai ML; Cronin N; Djordjevic S
    Acta Crystallogr D Biol Crystallogr; 2011 Jan; 67(Pt 1):14-24. PubMed ID: 21206058
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Selective PP2A Enhancement through Biased Heterotrimer Stabilization.
    Leonard D; Huang W; Izadmehr S; O'Connor CM; Wiredja DD; Wang Z; Zaware N; Chen Y; Schlatzer DM; Kiselar J; Vasireddi N; Schüchner S; Perl AL; Galsky MD; Xu W; Brautigan DL; Ogris E; Taylor DJ; Narla G
    Cell; 2020 Apr; 181(3):688-701.e16. PubMed ID: 32315618
    [TBL] [Abstract][Full Text] [Related]  

  • 76. To be or not to be: PP2A as a dual player in CNS functions, its role in neurodegeneration, and its interaction with brain insulin signaling.
    Javadpour P; Dargahi L; Ahmadiani A; Ghasemi R
    Cell Mol Life Sci; 2019 Jun; 76(12):2277-2297. PubMed ID: 30874837
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The role and therapeutic potential of Ser/Thr phosphatase PP2A in apoptotic signalling networks in human cancer cells.
    Janssens V; Rebollo A
    Curr Mol Med; 2012 Mar; 12(3):268-87. PubMed ID: 22300139
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Protein Phosphatase 2A (PP2A) mutations in brain function, development, and neurologic disease.
    Verbinnen I; Vaneynde P; Reynhout S; Lenaerts L; Derua R; Houge G; Janssens V
    Biochem Soc Trans; 2021 Aug; 49(4):1567-1588. PubMed ID: 34241636
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Identification of Integrator-PP2A complex (INTAC), an RNA polymerase II phosphatase.
    Zheng H; Qi Y; Hu S; Cao X; Xu C; Yin Z; Chen X; Li Y; Liu W; Li J; Wang J; Wei G; Liang K; Chen FX; Xu Y
    Science; 2020 Nov; 370(6520):. PubMed ID: 33243860
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.